Pure Global

Procyanidin B2 Enriched Cocoa Effects on Mitochondrial Biogenesis - Trial NCT04301583

Access comprehensive clinical trial information for NCT04301583 through Pure Global AI's free database. This phase not specified trial is sponsored by Universidad Europea de Madrid and is currently Completed. The study focuses on Athletes. Target enrollment is 38 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT04301583
Completed
dietary supplement
Trial Details
ClinicalTrials.gov โ€ข NCT04301583
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Procyanidin B2 Enriched Cocoa Effects on Mitochondrial Biogenesis

Study Focus

Athletes

procyanidin B2 enriched cocoa

Interventional

dietary supplement

Sponsor & Location

Universidad Europea de Madrid

Villaviciosa de Odรณn, Spain

Timeline & Enrollment

N/A

Jun 01, 2020

Sep 01, 2020

38 participants

Primary Outcome

Difference in mitochondrial number,Difference in exercise performance

Summary

The purpose of this study is to test how cocoa-rich procyanidin B2 affect the mitochondrial
 exercise adaptations.

ICD-10 Classifications

Examination for participation in sport
Striking against or struck by sports equipment
Routine general health check-up of sports teams

Data Source

ClinicalTrials.gov

NCT04301583

Non-Device Trial